Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today provided an update on the growing momentum of C-Sept™ PRO, a proprietary antiseptic solution from its high-margin infection-control portfolio, across leading public and private hospital groups in Greece.

C-Sept PRO has generated average monthly sales exceeding $93,000 over the past six months, accelerating to more than $108,000 per month over the past three months. This momentum places the product on track for annualized sales of over $1.3 million, generating approximately $0.9 million in annualized gross profit at a gross margin of approximately 72%. Demand has been driven by adoption across major public and private Greek hospital groups and a consistent pattern of repeat ordering, with growing momentum further supported by the Company’s participation in public hospital tenders.